Literature DB >> 14526315

The role of activity-dependent neuroprotective protein in a mouse model of fetal alcohol syndrome.

Sarah H Poggi1, Katie Goodwin, Joanna M Hill, Douglas E Brenneman, Elizabetta Tendi, Sergio Schinelli, Daniel Abebe, Catherine Y Spong.   

Abstract

OBJECTIVE: Fetal alcohol syndrome (FAS) is the most common nongenetic cause of mental retardation. Peptides NAPVSIPQ (NAP) and SALLRSIPA (SAL), related to activity-dependent neuroprotective protein (ADNP), prevent alcohol-induced damage in a mouse model of FAS. Our objective was to characterize ADNP in this model to relate this protein to the mechanisms of damage and peptide neuroprotection. STUDY
DESIGN: Timed, pregnant C57Bl6/J mice were treated on day 8. Groups were control, alcohol, peptide pretreatment, or peptide alone. Embryo and decidua were harvested at 6 and 24 hours and 10 days. To evaluate ADNP expression, real-time polymerase chain reaction was performed with results presented as the ratio of ADNP-to-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) concentration. Analysis of variance was performed for overall comparisons with P<.05 considered significant.
RESULTS: At 6 hours, there was no difference in ADNP between alcohol-exposed embryos compared with control embryos. At 24 hours, there was an increase in ADNP in alcohol-exposed embryos compared with controls (P<.001); these findings persisted at 10 days (P<.001). In the decidua at 6 hours, there was no difference between alcohol and control. At 24 hours, there was greater ADNP in alcohol-exposed decidua compared with controls (P<.001), which did not persist at 10 days (P=.97). Peptide pretreatment did not prevent the alcohol-induced increase in ADNP in embryo or decidua.
CONCLUSION: Alcohol increased embryonic and decidual ADNP expression at 24 hours and it persisted in the embryo for 10 days. Because ADNP is a known neuroprotectant, these findings suggest that it may be released as a protective mechanism in FAS. Changes in the embryo were persistent suggesting that the embryo is more vulnerable to alcohol-induced damage than the mother.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14526315     DOI: 10.1067/s0002-9378(03)00834-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

1.  Activity-dependent neuroprotective protein modulates its own gene expression.

Authors:  Moutasem S Aboonq; Sylvia A Vasiliou; Kate Haddley; John P Quinn; Vivien J Bubb
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

2.  Neuroprotective effects of PACAP against ethanol-induced toxicity in the developing rat cerebellum.

Authors:  Béatrice Botia; Valérie Jolivel; Delphine Burel; Vadim Le Joncour; Vincent Roy; Mickael Naassila; Magalie Bénard; Alain Fournier; Hubert Vaudry; David Vaudry
Journal:  Neurotox Res       Date:  2010-04-27       Impact factor: 3.911

3.  Brain delivery of NAP with PEG-PLGA nanoparticles modified with phage display peptides.

Authors:  Jingwei Li; Chi Zhang; Jing Li; Li Fan; Xinguo Jiang; Jun Chen; Zhiqing Pang; Qizhi Zhang
Journal:  Pharm Res       Date:  2013-04-03       Impact factor: 4.200

4.  Davunetide (NAP) protects the retina against early diabetic injury by reducing apoptotic death.

Authors:  Soraya Scuderi; Agata Grazia D'Amico; Alessandro Castorina; Concetta Federico; Giuseppina Marrazzo; Filippo Drago; Claudio Bucolo; Velia D'Agata
Journal:  J Mol Neurosci       Date:  2014-02-02       Impact factor: 3.444

5.  Activity-dependent neuroprotective protein-derived peptide, NAP, preventing alcohol-induced apoptosis in fetal brain of C57BL/6 mouse.

Authors:  Y Sari
Journal:  Neuroscience       Date:  2008-11-21       Impact factor: 3.590

6.  A novel peptide, colivelin, prevents alcohol-induced apoptosis in fetal brain of C57BL/6 mice: signaling pathway investigations.

Authors:  Y Sari; T Chiba; M Yamada; G V Rebec; S Aiso
Journal:  Neuroscience       Date:  2009-09-25       Impact factor: 3.590

7.  Brain injury-dependent expression of activity-dependent neuroprotective protein.

Authors:  Roy Zaltzman; Alexander Alexandrovich; Sara M Beni; Victoria Trembovler; Esther Shohami; Illana Gozes
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

8.  Blockage of VIP during mouse embryogenesis modifies adult behavior and results in permanent changes in brain chemistry.

Authors:  Joanna M Hill; Janet M Hauser; Lia M Sheppard; Daniel Abebe; Irit Spivak-Pohis; Michal Kushnir; Iris Deitch; Illana Gozes
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

9.  Alteration of gene expression by alcohol exposure at early neurulation.

Authors:  Feng C Zhou; Qianqian Zhao; Yunlong Liu; Charles R Goodlett; Tiebing Liang; Jeanette N McClintick; Howard J Edenberg; Lang Li
Journal:  BMC Genomics       Date:  2011-02-21       Impact factor: 3.969

10.  Prenatal treatment prevents learning deficit in Down syndrome model.

Authors:  Maddalena Incerti; Kari Horowitz; Robin Roberson; Daniel Abebe; Laura Toso; Madeline Caballero; Catherine Y Spong
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.